Pfizer Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with unit
Memorial Deadline: Friday 20th, February 2026
External Deadline: Wednesday 25th, February 2026
Description
Pfizer and the American Headache Society are collaborating to offer a new grant opportunity seeking proposals for quality improvement initiatives that will address quality gaps in headache medicine, with a goal of producing information or tools that can be widely used in the field and lead to measurable improvements in healthcare services for individuals with headache. Projects should also contribute to the core goal of the American Headache Society (AHS) – improving the lives of people impacted by migraine and other headache disorders
This competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval. The American Headache Society will select the Expert Review Panel (ERP) to make final grant decisions, create a community of practice for the selected Grantees and share existing knowledge and tools. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
For all quality improvement grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct or monitoring of the quality improvement program.
Date RFP Issued: December 3, 2025
Geographic Scope: United States and Canada
Clinical Area: Headache
Link to full RFP: Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders
Letter of Intent (LOI) Due Date: February 25, 2026
Specific Area of Interest: It is our intent to support quality improvement projects that focus on improving the lives of people impacted by migraine and other headache disorders. Projects should focus on safety, clinical effectiveness, rapidity of diagnosis/proper treatment, efficiency, patient centered care, and/or equity. Project proposals should align with the following core focus areas:
- – Diagnosis, treatment and management in primary care and non-headache specialty settings for adult populations
- – Collect and analyze patient experience data across multiple sites or a broad population
- – Innovative solutions for standardized delivery of headache care and exploration of AI applications in primary care and non-headache specialty settings
– Education specific to headache disorders in medical/allied health schools and residency training - Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Sue Lee (sue.lee@pfizer.com).